Specialty Pharmacists on the Frontline of Patient Access

There is a spotlight trained on the constant tug of war currently ongoing between payer and manufacturers regarding at-risk negotiations and drug costs. In the background, pharmacists are frequently left solo to handle the prior authorization and to ensure patient access to necessary medication. According to a November 2015 report from The Pew Charitable Trusts,… read more

Building a top secret, value-based weapon to improve patient engagement and access to care: A how-to guide

When it comes to treating population health, there is nothing that can replace the value of a real-life, caring person inquiring about a patient’s feelings, opinions and thoughts in order to identify barriers to medication access and adherence. Why is that? The square root of population health is the health of the individual patient. We’ve… read more

340B Coalition Winter Conference Takeaways: Mega-guidance and Audits

There were two prevailing topics that dominated this year’s 340B Coalition Winter Conference: mega-guidance and 340B entity audits. While these terms are not mutually exclusive, they each received significant airtime throughout the conference. The mystery of mega-guidance According to 340B Health, mega-guidance (aka omnibus guidance) is a ruling designed to be a ‘one-stop-shop’ of 340B-related… read more

The pros and cons of rising specialty drug costs

The increase of specialty drug costs is something that cannot be denied or ignored. According to a study done by the Kaiser Family Foundation and Truven Health Analytics, prescription drug spending accounts for 10% of the national spending on healthcare. The percentage is even higher for self-insured employers. Let’s talk about the two consequences, one… read more

Ways managed care executives can impact medication spending

Medication is getting pricier. We know the facts – the Kaiser Family Foundation and Truven Health Analytics calculate prescription drug spending at 10% of the total national health spend. Want to hear an even more shocking statistic? Drug spending alone in employer health plans tops out at a whopping 19% of total spend. There is… read more

What we’re looking forward to at the 2016 340B Winter Conference

Every winter 340B Health  brings key healthcare stakeholders together to discuss new 340B program developments, brainstorm and network at the 340B Coalition Winter Conference.  This event provides a terrific forum for education, discussion and insight into what’s working well with the program and where there are opportunities for improvement. As a leader in personalized medication… read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or klindsey@curanthealth.com

 
EmailEmailEmailEmail
Menu Title